Skip to search formSkip to main contentSkip to account menu

Familial Partial Lipodystrophy, Type 3

Known as: FPLD3, Lipodystrophy, Familial Partial, Associated With PPARg Mutations, Lipodystrophy, Familial Partial, Type 3 
This type can be caused by mutation in the gene encoding PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA.
National Institutes of Health

Related topics

Related topics

15 relations
Acanthosis NigricansAutosomal dominant inheritanceGestational DiabetesHyperglycemia

Broader (1)

Familial partial lipodystrophy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
PPARG Pro12Ala Ala carriers exhibit greater improvements in peripheral insulin sensitivity in response to 12 weeks of aerobic exercise training.
The Ala allele of PPARG Pro12Ala ( rs1801282 ) is associated with greater improvements to the glucose metabolism in exercise… 
Review
2019
Review
2019
Familial partial lipodystrophy type 3 complicated with recurrent pancreatitis: clinical analysis and literature review
Objective To analyze the clinical features of familial partial lipodystrophy type 3 (FPLD3) with recurrent pancreatitis and its… 
2015
2015
Peroxisome proliferator-activated receptor gamma (PPARG) rs1801282 C>G polymorphism is associated with cancer susceptibility in asians: an updated meta-analysis.
Peroxisome proliferator-activated receptor gamma (PPARG) is related to inflammation and plays an important role in the… 
2015
2015
Role of PPARG Pro12Ala in Malaysian Type 2 Diabetes Mellitus patients
2014
2014
Effect of creatine supplementation on physical performance are related to the AMPD1 and PPARG genes polymorphisms in football players.
The aim of this study was to evaluate the effects of short-term creatine supplementation on exercise performance in male athletes… 
2014
2014
Association of Variants in Genes Related to the Immune Response and Obesity with Benign Prostatic Hyperplasia in CLUE II
Background:Chronic inflammation and obesity may contribute to the genesis or progression of BPH and BPH-associated lower urinary… 
2010
2010
Relationship of five type 2 diabetes candidate gene polymorphisms to the age at diagnosis of diabetes in the Slovakian population.
OBJECTIVES To examine the relationship between polymorphisms of five candidate genes for type 2 diabetes mellitus (T2DM) and the… 
2009
2009
Single‐nucleotide polymorphism typing based on pyrosequencing chemistry and acryl‐modified glass chip
A new method (termed as “chip‐BAMPER” (bioluminometric assay coupled with modified primer extension reactions)) for single… 
2008
2008
Gene variants in young healthy subjects and their effects on biological variables of lipid status and obesity
Background.The correlation of gene variants with biological variables or clinical assessments has not been well understood… 
Review
2007
Review
2007
Peroxisome proliferator-activated receptor gamma polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes.
AIM One putative determinant of diabetic nephropathy is the Pro12Ala (P12A) polymorphism in the gene encoding peroxisome… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)